No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
180 |
4. Check minimum number of eventsNone |
180 |
5. Include endpointsNone |
180 |
6. Filter based on genotype QC (FinnGen only) |
180 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D75
- Name in latin
- Erythrocytosis familialis
Similar endpoints
↥List of similar endpoints to
Familial erythrocytosis
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1157 | 448 | 700 |
| Only index persons | 1033 | 383 | 650 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 56.72 | 59.64 | 54.64 |
| Only index persons | 55.02 | 57.68 | 53.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 70 | 110 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 56.29 | 56.48 | 56.18 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 167
- Matched controls
- 1669
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D75.0
ICD-10 Finland
Familial erythrocytosis
4503599627370496.0
236.0
166
*
D75.1
ICD-10 Finland
Secondary polycythaemia
+∞
41.4
38
*
D45
ICD-10 Finland
Polycythaemia vera
134.7
39.8
41
*
L01XX05
ATC
hydroxycarbamide; oral
173.9
28.6
29
*
XW000
NOMESCO Finland
Bone marrow biopsy
18.6
23.9
37
25
D75.2
ICD-10 Finland
Essential thrombocytosis
+∞
18.0
17
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
+∞
18.0
17
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
18.7
17.7
27
17
TPH00
NOMESCO Finland
Phlebotomy
151.6
13.7
14
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
11.6
11
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
35.2
8.2
10
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
7.3
7
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.8
7.1
54
246
SPAT1074
SPAT
Venesection
72.4
6.5
7
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
37
17
27.14
51.20
1.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
121
639
3.73
15.85
8.1
6.0
%
8.1
8.7
1.52
114
608
(3006504) Eosinophils/100 leukocytes in Blood
120
635
3.67
15.57
8.0
5.7
%
2.6
2.8
0.61
113
600
(3018010) Neutrophils/100 leukocytes in Blood
120
644
3.59
15.03
8.1
5.7
%
57.3
57.7
0.12
114
613
(3002030) Lymphocytes/100 leukocytes in Blood
121
654
3.59
14.96
9.0
5.9
%
28.6
27.2
0.58
116
618
(3022096) Basophils/100 leukocytes in Blood
117
621
3.53
14.86
7.8
5.6
%
0.8
0.7
0.89
111
585
(3006315) Basophils [#/volume] in Blood
122
675
3.51
14.27
7.3
5.7
e9/l
0.1
0.0
1.31
111
585
(3013115) Eosinophils [#/volume] in Blood
122
694
3.35
13.24
7.9
5.8
e9/l
0.2
0.2
0.43
114
611
(3001604) Monocytes [#/volume] in Blood
119
674
3.26
12.88
7.5
5.7
e9/l
0.6
0.6
0.87
108
580
(3019198) Lymphocytes [#/volume] in Blood
121
693
3.28
12.83
7.7
5.7
e9/l
2.1
1.8
1.19
114
609
(42870588) Differential panel, method unspecified - Blood
91
453
3.04
12.18
7.9
5.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
51
193
3.29
10.78
2.2
2.1
g/l
2.7
2.3
5.18
46
176
(3013650) Neutrophils [#/volume] in Blood by Automated count
125
787
2.93
10.16
10.3
9.1
e9/l
4.7
4.1
1.16
114
677
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
48
185
3.17
9.77
2.5
2.1
%
23.6
23.7
0.02
40
161
(40760892) CBC W Ordered Manual Differential panel - Blood
64
297
2.79
9.28
5.8
5.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
38
148
2.99
7.46
1.6
2.4
%
2.0
1.6
1.99
33
132
(3020682) Albumin/Creatinine [Ratio] in Urine
70
403
2.21
5.93
3.6
4.0
mg/mmol
5.5
10.3
0.99
50
254
(3023520) Reticulocytes [#/volume] in Blood
29
110
2.95
5.92
1.9
2.4
e9/l
90.2
65.7
3.20
22
86
(3045142) Bone marrow Pathology biopsy report
9
7
13.44
5.64
1.1
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
70
432
2.02
4.74
2.8
3.0
u/l
40.2
33.3
0.57
65
412
(3002256) Pathology report gross observation
32
144
2.49
4.69
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
90
610
1.95
4.63
8.6
9.4
e9/l
0.0
0.0
0.08
71
494
(3009508) Creatinine [Moles/volume] in Urine
67
414
1.98
4.48
2.8
3.0
mmol/l
8.6
7.9
0.55
60
350
(3012516) Albumin [Mass/volume] in Urine
62
377
1.98
4.32
2.7
3.2
mg/l
35.3
64.0
0.97
44
247
(3021440) Promyelocytes/100 leukocytes in Blood
26
112
2.54
4.16
4.8
4.9
%
0.1
0.2
0.64
13
34
(3017181) Myelocytes/100 leukocytes in Blood
27
121
2.45
3.98
4.8
4.8
%
0.9
1.1
0.14
14
39
(40758558) Short blood count panel - Blood
54
334
1.88
3.48
6.7
7.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
88
637
1.75
3.34
7.0
6.4
mmol/l
1.2
1.2
0.01
81
548
(3042936) Bacteria identified in Isolate by Culture
35
200
1.93
2.82
2.1
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
71
504
1.67
2.77
1.9
1.9
pmol/l
99.8
95.4
0.26
41
247
(3025159) Blasts/100 leukocytes in Blood
22
106
2.23
2.77
3.9
5.1
%
0.1
0.3
—
9
26
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
58
390
1.72
2.76
2.7
3.1
ng/l
1816.2
1222.9
0.41
47
333
(40768804) Tissue Pathology biopsy report
71
505
1.67
2.75
2.1
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
49
315
1.76
2.73
4.0
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
76
553
1.65
2.68
14.0
6.6
inr
1.3
1.2
0.38
13
163
(3038515) Glucose [Moles/volume] in Venous blood
10
33
3.15
2.57
3.9
3.2
mmol/l
7.6
7.9
—
10
33
(3013512) EKG study
58
398
1.67
2.54
4.5
4.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
21
104
2.15
2.48
4.6
5.0
%
1.5
0.4
—
10
20
(3004119) Hemoglobin [Mass/volume] in Venous blood
17
78
2.30
2.40
3.6
2.9
g/l
150.9
129.2
2.03
17
78
(3000093) Morphology [Interpretation] in Blood Narrative
5
8
6.39
2.38
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
10
35
2.97
2.34
3.9
3.1
mmol/l
2.3
1.5
—
10
35
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
15
66
2.39
2.31
4.1
3.4
%
46.5
47.9
0.06
15
66
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
23
3.59
2.30
3.1
2.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
13
4.73
2.29
3.7
3.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
73
2.31
2.29
1.8
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
18
4.00
2.27
1.1
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
123
2.00
2.24
3.3
2.0
nmol/l
321.6
373.8
0.77
23
112
(3013826) Glucose [Moles/volume] in Serum or Plasma
100
803
1.55
2.20
5.9
4.3
mmol/l
6.9
6.8
0.27
90
749
(3000330) Specific gravity of Urine by Test strip
15
68
2.32
2.18
4.2
4.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
148
1.88
2.12
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
10
5.11
2.08
1.2
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
14
63
2.33
2.07
3.4
3.0
mmol/l
24.7
25.0
0.14
14
63
(1761482) Bacteria [#/volume] in Urine by Culture
11
44
2.60
2.05
4.8
5.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
38
2.73
2.04
1.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
40
265
1.65
1.97
2.5
2.9
mosm/kgh2o
636.4
545.8
1.36
31
230
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
33
2.82
1.96
1.2
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
29
177
1.76
1.91
8.7
6.8
mmol/l
103.4
103.8
0.11
29
172
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
22
3.27
1.90
1.1
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
22
3.27
1.90
1.1
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
35
226
1.68
1.89
3.2
2.5
e6/l
0.6
1.0
0.73
22
128
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
12
4.25
1.83
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
12
4.25
1.83
2.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
137
1208
1.56
1.77
5.2
4.4
mu/l
1.8
1.9
0.63
129
1097
(3022621) pH of Urine by Test strip
16
82
2.04
1.76
2.7
2.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
13
3.92
1.72
1.2
1.2
nmol/l
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
50
362
1.53
1.69
3.0
3.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
23
137
1.78
1.65
3.7
2.1
nmol/l
12.7
15.0
1.01
23
128
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
14
3.64
1.62
6.0
2.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
32
2.57
1.61
1.3
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
63
483
1.47
1.61
3.0
2.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
15
78
2.01
1.59
10.9
7.7
mmol/l
25.2
24.6
0.59
15
72
(3004809) Band form neutrophils/100 leukocytes in Blood
6
20
3.07
1.59
8.8
2.3
%
1.8
2.4
—
6
15
(3002582) Erythrocytes [#/volume] in Urine
55
413
1.48
1.56
3.2
3.0
e6/l
105.4
195.9
0.22
46
314
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
27
2.66
1.53
2.4
2.6
e9/l
4.3
5.0
—
7
27
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
27
2.66
1.53
2.4
3.3
%
60.6
59.0
—
7
27
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
214
1.60
1.52
3.2
2.6
e6/l
2.7
2.2
0.12
19
118
(3021601) Nitrite [Presence] in Urine by Test strip
78
629
1.42
1.51
5.8
4.8
estimate
0.0
0.0
0.00
11
123
(3044640) Blood type and Crossmatch panel - Blood
55
416
1.46
1.50
4.7
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
56
427
1.45
1.46
2.1
2.3
u/l
47.6
54.5
1.53
49
394
(3044941) Cell count panel - Synovial fluid
5
16
3.18
1.45
1.0
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
78
635
1.40
1.41
3.8
3.6
estimate
0.0
0.0
0.00
11
116
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
144
1306
1.51
1.41
15.4
12.3
ml/min/173m2
80.0
82.3
0.61
131
1071
(3012544) pH of Venous blood
21
128
1.73
1.41
4.3
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
210
1.58
1.40
1.8
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
17
2.99
1.37
1.6
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
49
371
1.44
1.31
4.2
4.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
11
55
2.07
1.30
4.8
4.9
%
1.6
1.5
0.11
11
49
(3035350) Ketones [Presence] in Urine by Test strip
76
623
1.38
1.30
3.6
3.5
estimate
0.0
0.0
0.00
11
123
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
18
2.83
1.29
1.6
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
18
2.83
1.29
1.6
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
18
2.83
1.29
1.6
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
35
2.34
1.28
1.3
1.1
—
60.0
—
0
5
(3002032) Base excess in Venous blood by calculation
20
124
1.69
1.27
4.0
3.4
mmol/l
2.5
2.0
0.28
14
97
(3018095) Leukocytes [#/volume] in Urine
59
465
1.40
1.27
3.9
3.4
e6/l
96.8
38.5
0.57
46
336
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
25
2.45
1.25
1.2
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
19
2.68
1.22
1.6
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
19
2.68
1.22
1.6
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
628
1.36
1.22
5.9
3.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
38
279
1.46
1.19
1.4
1.7
mg/l
1.7
1.2
0.15
32
212
(3000850) Epithelial cells [#/volume] in Urine
37
272
1.45
1.15
2.2
2.6
e6/l
2.7
4.2
1.42
31
239
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
51
2.02
1.13
1.5
1.8
pmol/l
159.3
253.3
—
10
46
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
66
1.88
1.12
3.0
2.7
%
1.3
1.4
0.15
12
66
(3003327) Ova and parasites identified in Stool by Light microscopy
8
41
1.99
1.10
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
146
1.58
1.09
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
276
1.43
1.07
3.5
3.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
109
966
1.33
1.04
3.7
2.9
u/l
62.7
48.2
1.21
103
907
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1331
1.41
1.04
5.3
4.4
mmol/l
6.3
6.0
2.18
134
1220
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
148
1.55
1.04
1.7
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
34
2.10
1.04
2.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
150
1398
1.44
1.01
17.2
13.1
mg/l
19.3
24.0
1.17
126
1105
(3000764) Benzodiazepines [Presence] in Urine
9
49
1.88
1.00
1.8
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
10
54
1.90
0.98
5.2
5.1
%
0.8
0.9
—
10
49
(3041354) Potassium [Moles/volume] in Venous blood
5
23
2.21
0.98
4.8
3.0
mmol/l
4.2
4.1
—
5
23
(3035285) Chloride [Moles/volume] in Venous blood
5
23
2.21
0.98
4.8
3.0
mmol/l
106.4
106.2
—
5
23
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
23
2.21
0.98
4.8
3.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
50
1.84
0.98
1.9
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
50
1.84
0.98
1.8
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
25
176
1.49
0.97
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
437
1.34
0.96
3.6
3.8
%
21.5
21.8
0.05
25
188
(3028300) Cannabinoids [Presence] in Urine
9
51
1.80
0.96
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
37
1.93
0.95
4.4
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
47
375
1.34
0.92
3.3
2.9
e6/l
0.2
0.3
0.75
36
276
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
71
1.74
0.91
8.5
6.5
mmol/l
24.3
24.9
0.20
12
71
(3000991) Gas panel - Venous blood
17
112
1.57
0.88
10.7
7.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
24
173
1.45
0.84
23.0
23.9
inr
1.7
1.2
—
9
23
(3019060) Gas panel - Arterial blood
14
89
1.62
0.84
8.4
3.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
46
1.77
0.83
1.9
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
146
1370
1.35
0.81
5.3
4.3
mmol/l
1.2
1.4
9.02
139
1260
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
59
495
1.29
0.81
3.7
3.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
115
1.53
0.80
1.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
33
1.85
0.80
1.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
110
997
1.27
0.79
3.9
4.0
mm/h
7.4
11.6
4.21
105
915
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
229
0.67
0.77
1.4
1.9
—
—
—
0
0
(3020891) Body temperature
9
53
1.73
0.77
3.9
4.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
28
0.00
0.77
0.0
3.9
—
878.8
—
0
5
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
159
0.61
0.76
8.5
8.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
151
1.44
0.75
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
65
557
1.26
0.74
4.2
4.3
ug/l
1.7
2.5
0.71
60
494
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
35
276
1.33
0.74
1.2
1.2
u/ml
0.9
1.6
—
9
75
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
39
1.83
0.73
1.4
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
98
882
1.24
0.72
5.1
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
168
0.63
0.71
1.3
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
141
1326
1.29
0.69
5.1
3.9
mmol/l
1.6
1.3
4.39
135
1219
(3011288) Drugs identified in Urine by Screen method
5
27
1.88
0.69
3.2
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
28
1.81
0.66
1.4
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
62
1.65
0.66
5.6
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
147
1.41
0.65
3.1
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
104
950
1.22
0.64
3.8
3.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
29
1.74
0.64
1.6
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
63
547
1.23
0.63
3.6
3.7
ng/l
27.8
51.0
1.24
46
384
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
49
1.66
0.63
2.3
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
148
1406
1.30
0.63
6.0
4.8
mmol/l
2.7
2.8
0.59
142
1293
(3009542) Hematocrit [Volume Fraction] of Blood
136
1280
1.26
0.62
21.7
13.9
%
43.0
40.9
0.92
93
947
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(4010399)
14
98
1.46
0.58
2.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
142
1.38
0.57
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
325
1.26
0.56
2.7
2.8
ug/l
0.7
0.8
0.10
24
191
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
13
91
1.46
0.54
4.4
3.0
kpa
5.1
5.1
0.00
13
83
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
75
1.50
0.52
16.6
6.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
91
833
1.19
0.51
4.3
4.1
—
4055.2
—
0
14
(36304419) Bacteria [Presence] in Urine
43
367
1.23
0.50
3.3
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
176
0.72
0.49
1.5
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
92
846
1.18
0.48
2.9
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
47
1.51
0.48
2.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
43
371
1.21
0.46
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
50
1.42
0.45
2.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
31
1.63
0.43
1.2
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
21
168
1.28
0.42
4.1
5.0
mmol/l
1.0
1.1
0.06
21
156
(3007164) IgA [Mass/volume] in Serum or Plasma
31
261
1.23
0.42
1.5
1.3
g/l
2.2
2.4
0.45
22
157
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
16
0.00
0.41
0.0
3.3
—
41.4
—
0
5
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
137
0.71
0.41
1.4
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
34
1.48
0.40
1.6
1.2
—
—
—
0
0
(4268621)
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
66
1.38
0.39
1.1
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
43
1.41
0.35
10.2
4.0
mmol/l
3.9
3.9
—
6
38
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
43
1.41
0.35
2.2
1.2
g/l
0.2
0.2
—
6
43
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
73
1.39
0.35
1.4
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
45
1.34
0.34
1.8
1.2
g/l
1.2
1.2
—
6
45
(3018418) pH of Serum or Plasma
43
382
1.17
0.34
4.4
3.9
ph
7.4
7.4
—
6
62
(3037522) Nuclear Ab [Titer] in Serum
21
174
1.23
0.33
2.1
1.4
titre
1085.7
448.6
—
7
42
(3045414) Leukocytes [Presence] in Urine
7
52
1.36
0.31
1.9
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
227
0.82
0.30
1.4
1.3
iu/ml
11.6
33.3
—
5
77
(40761535) Cells panel - Urine sediment
8
106
0.74
0.30
3.6
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
56
1.26
0.30
2.1
2.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
16
131
1.24
0.28
15.4
7.4
g/l
131.4
121.3
1.15
16
124
(1002224) Polysomnography panel
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
56
516
1.12
0.26
4.1
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
126
0.78
0.25
1.4
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
257
1.15
0.24
5.2
3.4
ng/l
87.9
439.4
0.50
22
196
(3012095) Magnesium [Moles/volume] in Serum or Plasma
24
210
1.16
0.23
2.0
2.8
mmol/l
0.8
0.8
0.44
24
195
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
209
0.85
0.22
1.5
1.2
u/ml
9.5
8.7
—
6
80
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
1.7
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
7.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.5
—
33.8
—
0
5
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
8.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
20.8
—
0
10
(3004451) EKG impression Narrative
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3044927) Protein electrophoresis panel - Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
30
333
0.88
0.21
3.9
3.8
estimate
0.0
0.0
0.00
11
117
(4027681)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
7.5
—
0.6
—
0
12
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
2.8
—
130.0
—
0
12
(4094501)
5
43
1.17
0.21
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
159
1561
1.16
0.21
29.6
19.1
pg
30.0
30.3
0.73
159
1536
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
4.1
—
0
13
(3041096) Erythrocytes [Presence] in Urine by Automated
40
367
1.12
0.20
3.5
3.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
26
232
1.14
0.20
2.7
3.3
mmol/l
2.5
2.4
0.04
20
206
(3000963) Hemoglobin [Mass/volume] in Blood
159
1562
1.15
0.20
29.9
19.2
g/l
152.8
137.9
12.21
159
1536
(3024731) MCV [Entitic volume]
159
1562
1.15
0.20
29.7
19.1
fl
90.2
90.9
0.54
159
1537
(3020961) Endomysium IgA Ab [Titer] in Serum
7
60
1.17
0.18
1.3
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
152
1496
1.10
0.14
21.9
15.2
umol/l
81.1
79.7
0.28
152
1496
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
109
0.82
0.13
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
14
157
0.88
0.11
1.4
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
47
1.07
0.09
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
123
0.89
0.08
2.2
1.7
—
—
—
0
0
(3000492) Spirometry study
14
127
1.11
0.08
1.8
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
83
1.09
0.07
1.9
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
83
1.09
0.07
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
132
0.90
0.07
1.8
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
91
1.10
0.04
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
91
1.10
0.04
1.6
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
28
270
1.04
0.03
3.1
3.7
kg/l
1.0
1.0
—
6
32
(40761536) Microorganisms panel - Urine sediment
11
102
1.08
0.03
6.6
3.9
—
—
—
0
0
(3019225) pH of Specimen
13
123
1.06
0.01
2.8
4.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
147
1463
1.03
0.01
17.8
12.1
—
—
—
0
0
(4035726)
11
109
1.01
0.00
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
135
0.96
0.00
2.4
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
215
0.97
0.00
1.5
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
25
252
0.99
0.00
2.0
1.7
nmol/l
939.6
1219.0
0.99
20
197
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.2
—
116.7
—
0
9
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.8
—
103.8
—
0
5
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
54.8
—
0
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
33.2
—
89.8
—
0
5
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
17.8
—
0
5
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4281824)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
87
0.92
0.00
2.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
193.0
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
9
91
0.99
0.00
4.3
3.6
mmol/l
1.2
1.2
—
9
82
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
58
0.86
0.00
1.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
10.5
—
0
7
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
71
0.99
0.00
3.0
2.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
7.9
—
0
8
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
14.3
—
0
8
(3001019) Free T4 and TSH panel - Serum or Plasma
5
55
0.91
0.00
1.6
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
7.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
8.8
—
0
8
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
10.2
—
0
7
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
9
96
0.93
0.00
2.8
2.8
g/l
67.6
67.5
—
9
86
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_FAMIERYTHROCYTOCIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_FAMIERYTHROCYTOCIS | 2.131 [1.65, 2.76] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.091 |
During the follow-up period (1.1.1998 — 31.12.2019), 121 out of 403 females with D3_FAMIERYTHROCYTOCIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_FAMIERYTHROCYTOCIS | 1.315 [1.05, 1.65] | 0.018 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 131 out of 643 males with D3_FAMIERYTHROCYTOCIS died.
Mortality risk
Mortality risk for people of age
years, who have D3_FAMIERYTHROCYTOCIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.197% | 0.228% |
| 5 | 1.084% | 1.671% |
| 10 | 2.786% | 4.14% |
| 15 | 5.386% | 7.803% |
| 20 | 9.707% | 13.227% |
Relationships between endpoints
↥Index endpoint: D3_FAMIERYTHROCYTOCIS – Familial erythrocytosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data